Stage IA Breast Cancer Completed Phase 1 Trials for Sirolimus (DB00877)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01522820Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsTreatment